JP2022544380A5 - - Google Patents
Info
- Publication number
- JP2022544380A5 JP2022544380A5 JP2022508590A JP2022508590A JP2022544380A5 JP 2022544380 A5 JP2022544380 A5 JP 2022544380A5 JP 2022508590 A JP2022508590 A JP 2022508590A JP 2022508590 A JP2022508590 A JP 2022508590A JP 2022544380 A5 JP2022544380 A5 JP 2022544380A5
- Authority
- JP
- Japan
- Prior art keywords
- inventions described
- inventions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962884917P | 2019-08-09 | 2019-08-09 | |
| US62/884,917 | 2019-08-09 | ||
| US201962901206P | 2019-09-16 | 2019-09-16 | |
| US62/901,206 | 2019-09-16 | ||
| US201962947517P | 2019-12-12 | 2019-12-12 | |
| US62/947,517 | 2019-12-12 | ||
| US202063031299P | 2020-05-28 | 2020-05-28 | |
| US63/031,299 | 2020-05-28 | ||
| PCT/US2020/045442 WO2021030198A1 (en) | 2019-08-09 | 2020-08-07 | Compositions and methods for suppressing pathogenic organisms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544380A JP2022544380A (ja) | 2022-10-18 |
| JP2022544380A5 true JP2022544380A5 (https=) | 2023-08-17 |
| JP7846613B2 JP7846613B2 (ja) | 2026-04-15 |
Family
ID=74571198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022508590A Active JP7846613B2 (ja) | 2019-08-09 | 2020-08-07 | 病原菌を抑制するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220409674A1 (https=) |
| EP (1) | EP4010013A4 (https=) |
| JP (1) | JP7846613B2 (https=) |
| CN (1) | CN114502183A (https=) |
| WO (1) | WO2021030198A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3706767A4 (en) * | 2017-11-09 | 2021-12-15 | Vedanta Biosciences, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN ALLERGY |
| EP3723776A4 (en) | 2017-12-11 | 2022-07-27 | Vedanta Biosciences, Inc. | Compositions and methods for suppressing pathogenic organisms |
| GB202217266D0 (en) * | 2022-11-18 | 2023-01-04 | Imperial College Innovations Ltd | Anti-biotic-resistant bacteria |
| EP4687930A2 (en) * | 2023-01-30 | 2026-02-11 | Seres Therapeutics, Inc. | Use of designed bacterial compositions for infection treatment |
| EP4687931A1 (en) * | 2023-04-04 | 2026-02-11 | Vedanta Biosciences, Inc. | Compositions and methods for treating or preventing clostridium difficile infection, neutropenia, cardiovascular disease, asthma, and/or cancer |
| WO2025166242A1 (en) * | 2024-02-01 | 2025-08-07 | Vedanta Biosciences, Inc. | Compositions and methods for decreasing dysbiosis and/or preventing inflammatory bowel disease |
| EP4663196A1 (en) | 2024-06-13 | 2025-12-17 | Helmholtz-Zentrum für Infektionsforschung GmbH | Decolonization of pathogenic enterobacteria, such as e. coli and/or klebsiella pneumoniae, from the gut using strains of e. coli |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| WO2007075186A2 (en) * | 2005-04-18 | 2007-07-05 | The Regents Of The University Of California | Antimicrobial therapy for bacterial infections |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| US10973861B2 (en) * | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| EP2994758B1 (en) * | 2013-05-08 | 2017-12-20 | Opthea Limited | Biomarkers for age-related macular degeneration (amd) |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US9999641B2 (en) * | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| US20180000872A1 (en) * | 2016-07-01 | 2018-01-04 | Regents Of The University Of Minnesota | Compositions and methods for c. difficile treatment |
| WO2018023003A1 (en) * | 2016-07-29 | 2018-02-01 | Isothrive Llc | Optimized individualized prebiotic compositions |
| AU2017318650B2 (en) * | 2016-09-02 | 2021-12-09 | Société des Produits Nestlé S.A. | Compositions and methods for modulating gastrointestinal microflora in a canine |
| WO2018136884A1 (en) * | 2017-01-23 | 2018-07-26 | The Regents Of The University Of California | Compositions and methods for treating obesity and inducing weight loss |
| AU2018302641B2 (en) * | 2017-07-18 | 2024-12-19 | Keio University | Anti-bacterial composition against Th1 cell-inducing bacteria |
| EP3723776A4 (en) * | 2017-12-11 | 2022-07-27 | Vedanta Biosciences, Inc. | Compositions and methods for suppressing pathogenic organisms |
| CN117202919A (zh) * | 2021-02-18 | 2023-12-08 | 韦丹塔生物科学股份有限公司 | 用于抑制病原生物体的组合物和方法 |
-
2020
- 2020-08-07 JP JP2022508590A patent/JP7846613B2/ja active Active
- 2020-08-07 EP EP20852623.6A patent/EP4010013A4/en active Pending
- 2020-08-07 WO PCT/US2020/045442 patent/WO2021030198A1/en not_active Ceased
- 2020-08-07 CN CN202080070802.3A patent/CN114502183A/zh active Pending
- 2020-08-07 US US17/633,930 patent/US20220409674A1/en active Pending